BBA
ANAC
Baker Bros. Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-5,122,375
| Closed | -$274M | – | 142 |
|
|
2016
Q1 | $274M | Buy |
5,122,375
+923,855
| +22% | +$49.4M | 2.89% | 10 |
|
|
2015
Q4 | $474M | Buy |
4,198,520
+63,108
| +2% | +$7.13M | 3.93% | 9 |
|
|
2015
Q3 | $487M | Buy |
4,135,412
+509,914
| +14% | +$60M | 4.5% | 8 |
|
|
2015
Q2 | $281M | Sell |
3,625,498
-579,204
| -14% | -$44.8M | 2.46% | 11 |
|
|
2015
Q1 | $243M | Hold |
4,204,702
| – | – | 2.02% | 12 |
|
|
2014
Q4 | $136M | Hold |
4,204,702
| – | – | 1.38% | 13 |
|
|
2014
Q3 | $103M | Buy |
4,204,702
+956,659
| +29% | +$23.4M | 1.3% | 14 |
|
|
2014
Q2 | $57.6M | Buy |
3,248,043
+152,725
| +5% | +$2.71M | 0.71% | 20 |
|
|
2014
Q1 | $61.9M | Buy |
3,095,318
+595,318
| +24% | +$11.9M | 0.79% | 22 |
|
|
2013
Q4 | $42M | Buy |
2,500,000
+1,623,537
| +185% | +$27.2M | 0.59% | 24 |
|
|
2013
Q3 | $9.31M | Hold |
876,463
| – | – | 0.13% | 45 |
|
|
2013
Q2 | $4.9M | Buy |
+876,463
| New | +$4.9M | 0.1% | 48 |
|